Proscar: five-year experience.

  title={Proscar: five-year experience.},
  author={Erin Moore and Bruce R Bracken and William J. Bremner and Jack Geller and Julianne L Imperato-McGinley and John McConnell and Johnny B Roy and Lisa Tenover and David Vaughan and F. L. Pappas},
  journal={European urology},
  volume={28 4},
We assessed the long-term safety and efficacy of finasteride, an orally active 5 alpha-reductase inhibitor, in 2 previously reported groups of patients with symptomatic benign prostatic hyperplasia (BPH). Prostate volume was measured by magnetic resonance imaging, and the maximum urinary flow rate was assessed noninvasively. Symptoms were scored utilizing a… CONTINUE READING